Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
Ampronix
Fluke Biomedical

Robotic Hysterectomy Shows Little Benefit

By HospiMedica International staff writers
Posted on 05 Mar 2013
Rapid growth of robotic hysterectomy procedure volume continues despite a lack of data to support any advantages over conventional laparoscopic hysterectomy, claims a new study.

Researchers at Columbia University (New York, NY, USA) conducted a cohort study of 264,758 women who underwent hysterectomy for benign gynecologic disorders at 441 hospitals across the United States from 2007 to 2010. The researchers analyzed uptake of robotically assisted hysterectomy to determine the association between use of robotic surgery and rates of abdominal and laparoscopic hysterectomy, and to compare the in-house complications of both procedures. The main outcome measures were uptake of and factors associated with utilization of robotically assisted hysterectomy.

The results showed that the use of robotically assisted hysterectomy increased from 0.5% in 2007 to 9.5% of all hysterectomies in 2010; during the same time period, laparoscopic hysterectomy rates increased from 24.3% to 30.5%. The overall complication rates were similar for robotic-assisted and laparoscopic hysterectomy (5.5% versus 5.3%). Robotic-assisted hysterectomy patients were less likely to have a length of stay longer than two days, but transfusion requirements and the rate of discharge to a nursing facility were similar. Total costs associated with robotically assisted hysterectomy were USD 2,189 higher per case than for laparoscopic hysterectomy. The study was published in the February 20, 2012, issue of the Journal of the American Medical Association (JAMA).

“The uptake of laparoscopic hysterectomy has occurred slowly, given that the technique has been available since the 1990s. By comparison, uptake of robotic hysterectomy has been rapid,” said lead author Jason Wright, MD. “Our study indicates that, while robotic assistance was associated with increased use of minimally invasive surgery for hysterectomy, when compared with laparoscopic hysterectomy, the robotic procedure offers little short-term benefit and is accompanied by significantly higher costs.”

Robotically assisted surgery has several potential benefits that have driven interest in and use of the technology since the FDA approved the surgical platform in 2005. Among the possible benefits are a wider range of motion with instrumentation and three-dimensional (3D) stereoscopic visualization, and the fact that users can work from an ergonomically friendly console. Proponents of robotic hysterectomy have asserted that the approach extends minimally invasive surgery to women who otherwise would undergo laparotomy, but offer little supporting evidence to that claim.

Related Links:

Columbia University



Centurion Service
MinXray
Bovie Medical

Channels

Critical Care

view channel
Image: The Trellis peripheral infusion system (Photo courtesy of Covidien).

Thrombolytic Drug Delivery Device Dissolves Blood Clots

A redesigned peripheral infusion system enables focused treatment of blood clots to avoid potential post-thrombotic syndrome (PTS). The updated Trellis peripheral infusion system is a pharmacomechanical... Read more

Women's Health

view channel
Image: A prototype contraceptive implant (Photo courtesy of MicroCHIPS).

Contraceptive Implant Hails New Era of Birth Control

A fingernail-sized implant holds enough 30-microgram daily doses of levonorgestrel to provide contraception for 16 years. Developed by MicroCHIPS (Lexington, MA, USA), a MIT (Cambridge, MA, USA) startup,... Read more

Health IT

view channel
Image: The Health eResearch Center UV2 supercomputer (Photo courtesy of HeRC).

Supercomputer Accelerates Pace of Health Research

The University of Manchester (United Kingdom) is financing a new supercomputer system that can analyze bigger and more complex sets of information. The Health eResearch Center (HeRC; Manchester, United... Read more

Business

view channel

Spectranetics Completes Acquisition of AngioScore

Spectranetics (Colorado Springs, CO, USA) has completed the acquisition of AngioScore (Fremont, CA, USA), a leading developer, manufacturer, and marketer of cardiovascular specialty balloons. The transaction, for USD 230 million in cash and contingent commercial and regulatory milestone payments, will combine differentiated,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.